OmniActive Sponsors Informa’s Premier Curcumin Webinar
Morristown, N.J., Feb. 17, 2017 – OmniActive Health Technologies will sponsor Informa’s live webinar “How Science and Technology Reinforce Curcumin’s Efficacy for Dietary Supplements” on Tuesday, Feb. 28th at 2:00 p.m. EST.
The session will feature an expert marketing and science panel including Christopher Shanahan, MS, Global Program Manager, Frost & Sullivan, Melinda Fernyhough Culver DVM, PhD, Director of Scientic Affairs, OmniActive Health Technologies and Jonathan Oliver, PhD., Assistant Professor at Texas Christian University. During the session, attendees will gain insight into the current challenges and critiques affecting curcumin’s legitimacy as a dietary supplement.
“Curcumin’s meteoric rise in popularity is the result of high consumer interest and a large body of research supporting its efficacy and safety,” said Lynda M. Doyle, Sr. VP, OmniActive Health Technologies. “This webinar offers guidelines for building substantiation through well-designed, human clinical trials that provide focused formula solutions for consumers and to reinforce curcumin’s continued success in the market.”
For more details or to register https://engage.vevent.com/index.jsp?eid=6829&seid=1047.
About OmniActive Health Technologies, Inc.:
OmniActive Health Technologies (www.omniactives.com) offers a range of quality ingredients that are innovative and scientifically validated to address complex challenges for customers in the dietary supplement, food and beverage space using technology-driven, sustainable solutions with application support within a global regulatory framework. OmniActive’s core products include carotenoids, plant extracts and specialty functional ingredients. The company develops IP-protected, science-backed branded ingredients from natural sources using cutting edge technologies.
OmniActive leverages international R&D strengths to deploy an array of state of the art manufacturing technologies in extraction, purification, isolation and delivery of nutritional actives. Clinical research geared towards demonstrating efficacy and claim substantiation is the cornerstone of OmniActive’s R&D activities. The company’s centers of excellence are located in North America and India, whereas its cGMP and HACCP system-compliant manufacturing operations are located at multiple FDA inspected sites in India. Whether looking for a new ingredient to add to a finished product, or technology to enhance an existing ingredient, OmniActive delivers unmatched innovation.